GlassScriptPhysician profile
Han Hwang
NPI 1144849753
$2,062.57
in general payments reported to CMS, 2019-2025
10 companies · $876 in 2025
The $876 reported for 2025 was more than what 85% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $127 · 2023: $148 · 2024: $646 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.40 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $758.37 | 2022-2025 | Wegovy |
| Lilly USA, LLC | $652.95 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Phathom Pharmaceuticals, INC. | $176.24 | 2025 | Voquezna |
| Vivus LLC | $128.92 | 2021-2025 | Qsymia, Pancreaze |
| Janssen Pharmaceuticals, INC | $123.73 | 2021 | |
| Allergan, INC. | $111.39 | 2021 | |
| Exact Sciences Corporation | $40.73 | 2025 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $28.65 | 2021-2025 | Contrave |
| Boston Scientific Corporation | $24.14 | 2024 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $17.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.